The estimated Net Worth of Adam Lenkowsky is at least $673 mil dollars as of 10 March 2024. Adam Lenkowsky owns over 15,016 units of Bristol-Myers Squibb Co stock worth over $673,409 and over the last 2 years Adam sold BMY stock worth over $0.
Adam has made over 2 trades of the Bristol-Myers Squibb Co stock since 2023, according to the Form 4 filled with the SEC. Most recently Adam exercised 15,016 units of BMY stock worth $729,627 on 10 March 2024.
The largest trade Adam's ever made was exercising 15,016 units of Bristol-Myers Squibb Co stock on 10 March 2024 worth over $729,627. On average, Adam trades about 4,023 units every 70 days since 2023. As of 10 March 2024 Adam still owns at least 13,859 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Adam Lenkowsky stock trades at the bottom of the page.
Adam's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius y Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: